325 related articles for article (PubMed ID: 18790753)
21. Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
Steg A; Amm HM; Novak Z; Frost AR; Johnson MR
Cancer Biol Ther; 2010 Nov; 10(9):893-902. PubMed ID: 20814245
[TBL] [Abstract][Full Text] [Related]
22. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma.
Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY
Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353
[TBL] [Abstract][Full Text] [Related]
24. Hedgehog inhibition with the orally bioavailable Smo antagonist LDE225 represses tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms.
Fendrich V; Wiese D; Waldmann J; Lauth M; Heverhagen AE; Rehm J; Bartsch DK
Ann Surg; 2011 Nov; 254(5):818-23; discussion 823. PubMed ID: 22042473
[TBL] [Abstract][Full Text] [Related]
25. Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells.
Yamazaki M; Nakamura K; Mizukami Y; Ii M; Sasajima J; Sugiyama Y; Nishikawa T; Nakano Y; Yanagawa N; Sato K; Maemoto A; Tanno S; Okumura T; Karasaki H; Kono T; Fujiya M; Ashida T; Chung DC; Kohgo Y
Cancer Sci; 2008 Jun; 99(6):1131-8. PubMed ID: 18422746
[TBL] [Abstract][Full Text] [Related]
26. Combining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis.
Gu D; Liu H; Su GH; Zhang X; Chin-Sinex H; Hanenberg H; Mendonca MS; Shannon HE; Chiorean EG; Xie J
Mol Cancer Ther; 2013 Jun; 12(6):1038-48. PubMed ID: 23468532
[TBL] [Abstract][Full Text] [Related]
27. [Effects and mechanisms of combined suppression of epidermal growth factor receptor and hedgehog signaling on proliferation in pancreatic cancer cells].
Qin CF; Tian XD; Hao K; Yang YM
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(26):1849-53. PubMed ID: 22944238
[TBL] [Abstract][Full Text] [Related]
28. New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha.
Rifai Y; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Bioorg Med Chem Lett; 2011 Jan; 21(2):718-22. PubMed ID: 21190854
[TBL] [Abstract][Full Text] [Related]
29. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
Bisht S; Brossart P; Maitra A; Feldmann G
Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
[TBL] [Abstract][Full Text] [Related]
30. Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer.
Fan C; Wang Y; Liu Z; Sun Y; Wang X; Wei G; Wei J
Int J Mol Med; 2015 Jul; 36(1):204-14. PubMed ID: 25999130
[TBL] [Abstract][Full Text] [Related]
31. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
32. Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition.
Chang Q; Foltz WD; Chaudary N; Hill RP; Hedley DW
Int J Cancer; 2013 Jul; 133(1):225-34. PubMed ID: 23280784
[TBL] [Abstract][Full Text] [Related]
33. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.
Tambe Y; Terado T; Kim CJ; Mukaisho KI; Yoshida S; Sugihara H; Tanaka H; Chida J; Kido H; Yamaji K; Yamamoto T; Nakano H; Omura S; Inoue H
Mol Carcinog; 2019 Oct; 58(10):1726-1737. PubMed ID: 31106493
[TBL] [Abstract][Full Text] [Related]
35. Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Under Hypoxia, Suppressing the Malignant Phenotype in Pancreatic Cancer.
Yamasaki A; Onishi H; Imaizumi A; Kawamoto M; Fujimura A; Oyama Y; Katano M
Anticancer Res; 2016 Aug; 36(8):3945-52. PubMed ID: 27466498
[TBL] [Abstract][Full Text] [Related]
36. Targeting the hedgehog signaling pathway with interacting peptides to Patched-1.
Nakamura M; Tanaka H; Nagayoshi Y; Nakashima H; Tsutsumi K; Ohtsuka T; Takahata S; Tanaka M; Okada H
J Gastroenterol; 2012 Apr; 47(4):452-60. PubMed ID: 22170414
[TBL] [Abstract][Full Text] [Related]
37. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
[TBL] [Abstract][Full Text] [Related]
38. A novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse model.
Strand MF; Wilson SR; Dembinski JL; Holsworth DD; Khvat A; Okun I; Petersen D; Krauss S
PLoS One; 2011; 6(6):e19904. PubMed ID: 21698280
[TBL] [Abstract][Full Text] [Related]
39. Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms.
Singh BN; Fu J; Srivastava RK; Shankar S
PLoS One; 2011; 6(11):e27306. PubMed ID: 22087285
[TBL] [Abstract][Full Text] [Related]
40. Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines.
Thievessen I; Wolter M; Prior A; Seifert HH; Schulz WA
J Cell Physiol; 2005 May; 203(2):372-7. PubMed ID: 15521068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
